bioRxivBiophysics
Structure Basis for Inhibition of SARS-CoV-2 by the Feline Drug GC376
X. Luan, W. Shang, Y. Wang, W. Yin, Y. Jiang, S. Feng, Y. Wang, M. Liu, R. Zhou, Z. Zhang, F. Wang, C. Wang, M. Gao, H. Wang, W. Wu, R. Tian, Z. Tian, Y. Jin, H. Jiang, L. Zhang, H. E. Xu, S. Zhang
Abstract
The pandemic of SARS-CoV-2 coronavirus disease-2019 (COVID-19) caused by SARS-COV-2 continues to ravage many countries in the world. Mpro is an indispensable protein for viral translation in SARS-CoV-2 and a potential target in high-specificity anti-SARS-CoV-2 drug screening. In this study, to explore potential drugs for treating COVID-19, we elucidated the structure of SARS-CoV-2 Mpro and explored the interaction between Mpro and GC376, an antiviral drug used to treat a range of coronaviruses in Feline via inhibiting Mpro. The availability and safety of GC376 were proved by biochemical and cell experiments in vitro. We determined the structure of an important protein, Mpro, in SARS-CoV-2, and revealed the interaction of GC376 with the viral substrate and inhibition of the catalytic site of SARS-CoV-2 Mpro.
- organism: virus
- assay: structural biology
- research focus: host-pathogen & immune response
- research focus: protein structure prediction
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- N-Terminal finger stabilizes the reversible feline drug GC376 in SARS-CoV-2 Mpro
E. Arutyunova, M. B. Khan, … M. J. Lemieux·bioRxiv·Feb 16, 2021
- Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
W. Vuong, M. B. Khan, … M. J. Lemieux·bioRxiv·May 3, 2020
- Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L
M. D. Sacco, C. Ma, … J. Wang·Science AdvancesPeer-reviewed·Dec 11, 2020
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
C. Ma, M. D. Sacco, … J. Wang·Cell ResearchPeer-reviewed·Jun 15, 2020
- An expedited approach towards the rationale design of non-covalent SARS-CoV-2 main protease inhibitors with in vitro antiviral activity
N. Kitamura, M. D. Sacco, … J. Wang·bioRxiv·Dec 19, 2020
- Structural basis for the inhibition of coronaviral main proteases by PF-00835231
Xuelan Zhou, Xiaolu Lu, … Jian Li·Acta Biochimica et Biophysica SinicaPeer-reviewed·Jul 29, 2024